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Solanum torvum Swartz is a well-known traditional herbal medicinal plant used in diabetes and diabetes-related 
complications. The objective of the study was to evaluate the effect of S. torvum on diabetic neuropathy in alloxan-induced 
diabetic rats. Diabetes was induced in Wistar rats by using a single intraperitoneal injection of alloxan monohydrate (150 
mg/kg; i.p.). After confirmation of diabetes, rats received metformin (120 mg/kg, p.o.) and STME (30 and 100 mg/kg, p.o) 
for 5 weeks. Diabetic rats showed significant (P <0.05) behavioural changes, increase in blood glucose levels, decrease in 
relative organ weight of pancreas, significant (P <0.05) decrease in reduced glutathione (RGSH) and significant (P <0.05) 
increase in TBARS levels. While STME (100 mg/kg) treated diabetic rats significantly (P <0.05) reversed the above 
parameters as compared to diabetic rats. Treatment with STME (100 mg/kg) has also reversed histopathological changes as 
observed in diabetic control rats. The study suggests that methanolic extract of S. torvum ameliorates diabetic neuropathy in 
alloxan-induced diabetic rats. 
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Introduction 
Diabetic neuropathy (DN) is a chronic 
complication of both type I and type II diabetes 
mellitus (DM). Patients with long term diabetes may 
develop complications affecting the eyes, kidneys or 
nerves (microvascular complications) or major 
arteries. Diabetic neuropathy is nerve damaging 
disorder associated with DM. Neuropathic pain is 
characterized by the sensory abnormalities such as 
unpleasant abnormal sensation (dysesthesia), an 
increased response to painful stimuli (hyperalgesia), 
and pain in response to the stimulus that does not 
normally provoke pain (allodynia). Various proposed 
mechanisms which lead to pathogenesis of DN are 
activated polyol pathway, AGE’s (Advanced 
glycation end products) formation PKC (Protein 
kinase C) activation and hexosamine pathway. 
Hyperglycemia is the primary cause of DN. There has 
been a major advance in the control of hyperglycemia 
(diabetes), through dietary changes, hypoglycemic 
agents, insulin and islet transplantation, even though 
the long term complication of diabetes, such as 
neuropathy remains a serious problem1. Therefore, 
agents or compounds that exert multiple actions, such 
as antioxidants, antidiabetic/hypoglycemic and 
antiglycation properties could be more effective than 
agents with a single action2. Alloxan-induced diabetes 
is one of the commonly used models to induce DM in 
the experimental animal. Alloxan has found to be 
selectively toxic to pancreatic beta cell as it 
preferentially accumulates in the beta cells as glucose 
analogues. In addition, the cytotoxic action of alloxan 
is mediated mainly by the generation of reactive 
oxygen species (ROS). Alloxan and its reductive 
product, dialuric acid, has been noted to develop 
redox cycle with the formation of superoxide radicals, 
which undergo dismutation to hydrogen peroxide 3. 
Alloxan is the most leading chemical compound used 
in diabetogenic research. In research, it is used for 
induction of Type 1 diabetes. Alloxan is urea 
derivative which causes selective necrosis of β-cells 
of pancreatic islet. Chemical induction with alloxan 
appears to be the easiest, reliable and the most 
practicable method of inducing diabetes mellitus in 
rodents4. It is generally used to induce experimental 
diabetes in an animal such as rabbits, rats, mice and 
dogs with different grades of disease severity by 









Solanum torvum Swartz (Family Solanaceae) is 
commonly known as Turkey berry. It possesses 
antimicrobial6, antiviral7, immunosecretory8, 
antiulcer9, antioxidant10, analgesic and anti-
inflammatory11 activities in animal models. In earlier 
studies, cardioprotective12, hepatoprotective13, and 
nephroprotective14 activity of S. torvum against 
doxorubicin-induced toxicities in Wistar rats have 
been studied, and antihypertensive and metabolic 
correction activity in fructose hypertensive rats15 has 
also been reported. The plant due to their 
immunomodulatory and antioxidant property may be 
used in the treatment of benign prostatic 
hyperplasia16. The alkaloid fraction of leaf extract of 
S. torvum has been reported to be neuroprotective on 
Drosophila melanogaster against β-Amyloid induced 
Alzheimer disease17. Dietary flavonoids and alkaloids 
exert cardioprotective, chemopreventive, and 
neuroprotective effects too. The biological activities 
of phytoconstituents have been attributed to their 
antioxidant, antiinflammatory, and signalling 
properties18. Some plants of genus Solanum have been 
used in folk medicine as antidiabetic19,20. In view of 
the above literature, the present study has been 
designed to evaluate the ameliorative effect of S. 
torvum against diabetic neuropathy in alloxan-induced 
diabetic rats. 
 
Materials and Methods 
Drugs and chemicals 
Alloxan monohydrate (Sigma-Aldrich Chemicals 
Pvt. Ltd., USA.), Ascorbic acid (Research lab), Pet 
ether 60-80 oC (Research lab), Methanol (Research 
lab), Metronidazole (Kirti Pharma, Musalgaon, 
Nasik), Acetone (Sigma), TBA (Sigma) & TCA 
(Research lab), DTNB (Sigma) and glucometer 
(Accucheck) were used for the study. 
 
Preparation of extract 
Seeds of S. torvum were purchased from 
Tirunelvelli district of Tamil Nadu in May 2017 and 
authenticated from Ayurved Sanshodhan Vibhag, 
Nashik (Voucher specimen No-ASV0978). Mature 
fruits were dried in shade and grounded. The powder 
obtained was defatted using pet ether (60–80 oC). The 
marc obtained was dried and further extracted with 
methanol solution using soxhlet extractor. The extract 
obtained was dried under the vaccum in reduced 
pressure (1400 psi) then evaporated to obtain 11.6% 
w/w of methanolic extract of S. torvum. The pH of the 
methanolic extract was found to be 6.821. 
Animals 
Wistar rats of either sex weighing around 150-200 
g were purchased from Bombay Veterinary College, 
Parel. Animals were housed separately in groups of 6 
animals per cage under standard laboratory conditions 
maintained at a temperature (22-24 °C) and humidity 
(50-60%) with light and dark cycle of 12 hours each. 
The animals were acclimatized for at least five days 
before behavioural studies. All experiments were 
carried out during day time between 09:00 and 16:00 
hours. All animals had proper access to standard food 
and water. Study protocol was approved by the 
Institutional Animal Ethics Committee 
(MGV/PC/CPCSEA /XXXIV/01/2017/02), Government 
of India, New Delhi. 
 
Experimental design 
Animals were divided into 5 groups of 6 rats 
(either sex) each and treated for 5 weeks. Group I 
Normal control received vehicle as saline only  
(10 mL/kg). Group II Rats treated with Alloxan 
monohydrate (150 mg/kg; i.p.) once only. Group III 
Diabetic rats treated with metformin (120 mg/kg; p.o.) 
once every day for 5 weeks. Group IV diabetic rats 
treated with S. torvum methanolic extract (30 mg/kg; 
p.o.) once every day for 5 weeks. Group V diabetic 
rats treated with S. torvum methanolic extract  
(100 mg/kg; p.o.) once every day for 5 weeks. During 
the treatment schedule, all groups were subjected to 
morphological and behavioural tests once a week for 
5 weeks. At the end of the treatment schedule, 
antioxidant, relative organ weight and 
histopathological tests were performed. 
 
In vitro test 
In vitro glucose uptake by yeast cell 
The commercial baker’s yeast in distilled water 
was subjected to centrifugation (3000× g, 5 min) 
until clear supernatant fluids were obtained and a 
10% (v/v) of suspension was prepared in distilled 
water. Various concentrations of plant extracts (5-
100 μg/mL) were added to 1 mL of glucose 
solutions (5, 10, and 25 mM) and incubated 
together for 10 minutes at 37 °C. Reaction was 
started by adding 100 μL of yeast suspension 
followed by incubation at 37 °C for 60 minutes. 
After 60 minutes, the tubes were centrifuged at 
2500 rpm for 5 minutes (R-24) and amount of 
glucose was estimated in the supernatant21. 
Metronidazole was used as standard drug. The 
percentage increase in glucose uptake by yeast cells 
was calculated using the following formula: 




Increase in glucose uptake (%) = Abs (sample) – 
Abs (control) /Abs (sample) ×100 
 
Morphological study 
Body weight and water intake were monitored once 
in a week. 
 
Behavioural study 
Tail immersion test (Cold water) 
Distal 5 cm of rat’s tail was immersed in cold water 
maintained at 10 °C. Time taken for withdrawal of tail 
from cold water was noted. A cut off time of 20 
seconds was maintained to prevent tissue injury. The 
procedure was repeated 3 times for each animal. The 
decrease in tail contact time with cold water, indicated 
nociception, whereas prolonged contact time 
indicated anti-allodynic effect22. 
 
Tail immersion test (Hot water) 
Heat hyperalgesia was measured by immersion of 
the terminal part of the tail (1 cm) in warm water 
maintained at 52.5±0.5 °C. The duration of tail 
withdrawal reflex was recorded as a response of heat 
thermal sensation and a cut off time of 15 seconds 
was maintained. Shortening of tail withdrawal time is 
an indicator of thermal hyperalgesia23. 
 
Acetone drop method 
Cold chemical thermal sensitivity was assessed 
using acetone drop method. Rats were placed in a 
metal mesh cage and allowed to habituate for 
approximately 20 minutes. Acetone drop (50 μL) was 
applied gently on to the mid plantar surface of the 
hind paw. It generates a cold chemical sensitive 
reaction that is paw liking, shaking or rubbing the 
hind paw with brisk foot withdrawal after application 
(2-5 sec) of acetone which was considered as anti-
nociceptive effect24. 
 
Rota rod test 
This test was conducted using rota rod apparatus by 
placing rats on 15 rpm rotating spindle. The fall off 
time of each rat from rotating spindle was recorded 
during 5 minutes period25. 
 
Hot plate method 
The nociceptive threshold for heat is an index for 
thermal hyperalgesia. The plate was preheated and 
maintained at a temperature of 52.5±2 °C. A rat was 
placed on the hot plate and nociceptive threshold with 
respect to licking of the hind paw or jumping will be 
recorded in seconds. The onset of licking and jumping 
response was recorded. The cut off time of 20 seconds 
was maintained26. 
Blood glucose levels 
Rats were kept in restrainers; their tail was cleaned 
with warm soap solution using cotton. Blood samples 
were withdrawn from the tail vein under mild 
isoflurane anaesthesia. Blood glucose levels were 
monitored after 72 hours of induction of diabetes by 
alloxan monohydrate (150 mg/kg, i.p.). Blood glucose 
levels were monitored by using a glucometer 
(Accucheck) to confirm hyperglycemia. 
Hyperglycemic rats (glucose level >200 mg/dL) were 
separated and selected for the study. Blood glucose 
levels were also measured at the end of 5 weeks of 
treatment in all groups. 
 
Antioxidant study 
Preparation of serum and tissue homogenate 
Under light isoflurane anaesthesia blood samples 
were withdrawn by cardiac puncture. Serum was 
separated by centrifugation at 3000 rpm for  
10 minutes using REMI-Centrifuge (R-24). The 
serum samples were maintained at (-20 °C) to be used 
for measurement of RGSH. The pancreas was 
dissected out, immediately washed in ice-cold saline, 
dried and weighed for measurement of relative organ 
weight and homogenized (REMI motors, RQ-127A) 
in ice-cold 0.1 M Tris-HCl buffer for estimation of 
TBARS. 
 
RGSH (Reduced Glutathione) 
About 1 mL homogenate (pancreatic) was added to 
1 mL of 10% trichloroacetic acid, followed by 
centrifugation. Then, 1 mL supernatant was collected 
and 5 mL Ellman’s reagent in 100 mL of 1% sodium 
citrate and 3 mL of phosphate buffer (pH 8) was 
added. Change in colour was noted. Absorbance was 
taken at 412 nm and results were expressed as nM/mg 
of wet tissue of RGSH activity27. 
 
TBARS (Thiobarbituric Acid) 
Test tubes containing 100 μL serum, 1 mL 
trichloroacetic acid (20%) and 1 mL thiobarbituric 
acid reagent (1%) were incubated at 100 °C for 30 
min, followed by cooling on ice bath and 
centrifugation at 1000 g (20 minutes). Absorbance 
was taken at 532 nm28. 
 
Histopathological analysis of sciatic nerve 
Histopathological study was done at 
Histopathological lab (Clinpath lab, Nashik). The left 
thigh area was shaved and then prepared for surgery. 
The sciatic nerve was exposed through a skin incision 
and gluteal muscle splitting. Then sciatic nerve was 




cut into 4 μmm thickness and then kept in the 10% 
formalin (fixation solution). Staining was done using 
hematoxyline and eosin. Then cross-sections were 
observed using a light microscope (100×) for axonal 
degeneration and vascular defects29. 
 
Statistical analysis 
Data were analyzed using PRIMER statistical 
software and expressed as Mean±SEM. Statistical 
analysis was done using One-way ANOVA, followed 




In vitro glucose uptake by yeast cell 
Percentage uptake of glucose by yeast cells was 
increased with increasing dose of STME at various 
concentrations of glucose (5, 10, and 25 mM). The 
methanolic extract of S. torvum at higher 
concentrations (above 40 μg/mL) exhibited glucose 
uptake activity comparable with standard 




After second week of induction of diabetes, there 
was significant (P <0.05) decrease in body weight of 
diabetic control rats as compared to normal control 
rats. Diabetic rats treated with standard metformin 
(120 mg/kg) and diabetic rats treated with S. torvum 
methanolic extract (30 and 100 mg/kg) showed 
significant improvement in body weight as compared 
to diabetic control rats in the 4th and 5th week of 
treatment schedule (Fig. 4). 
 
Water intake 
There was a decrease in water intake in diabetic 
control rats as compared with normal control, 
metformin and STME treated diabetic rats. 
 
Behavioural tests 
Tail immersion in cold water 
Cold allodynia was observed in the diabetic rats at 
the 3rd week of induction of diabetes. Cold allodynia 
was indicated by shortening of tail withdrawal latency 
as compared to normal rats. Diabetic rats treated with 
metformin (120 mg/kg) and S. torvum methanolic 
extract (100 mg/kg) showed significant  
(P <0.05) improvement in tail withdrawal latency in 
3rd, 4th, and 5th week of treatment schedule as 
compared to diabetic control rats (Fig. 5). 
 
Tail immersion in hot water 
Heat hyperalgesia was observed in diabetic rats at 
the 3rd week of induction of diabetes. Heat 
 
 
Fig. 1 — The comparative % increase in glucose uptake by yeast
cells by Solanum torvum and Standard drug Metronidazole at 5
mM glucose concentration.  
(Values are expressed as mean±SD, N=6) ; STME- Solanum 




Fig. 2 — The comparative % increase in glucose uptake by yeast
cells by Solanum torvum extract and Standard drug Metronidazole 
at 10 mM glucose concentration. 
(Values are expressed as mean±SD, N=6); STME- Solanum 




Fig. 3 — The comparative % increase in glucose uptake by yeast
cells by Solanum torvum and Standard drug Metronidazole at 25
mM glucose concentration. 
(Values are expressed as mean±SD, N=6); STME- Solanum 
torvum methanolic extract. 
 
 
Fig. 4 — Effect of STME (30 and 100 mg/kg) and Metformin
(120 mg/kg) on body weight in Alloxan induced diabetic
neuropathy in diabetic rats. 
N= 6, all data were subjected to ANOVA followed by Dunnett’s
test, the observations are mean±SEM. *P <0.05 as compared to 
normal control group and # P <0.05 as compared to diabetic 
control group; STME- Solanum torvum methanolic extract. 




hyperalgesia was indicated by a significant reduction 
in tail withdrawal latency as compared to normal rats. 
Diabetic rats treated with metformin (120 mg/kg) and 
S. torvum methanolic extract (100 mg/kg) showed 
significant (P <0.05) improvement in tail withdrawal 
latency in 3rd, 4th, and 5th week of treatment schedule 
as compared to diabetic control rats (Fig. 6). 
 
Acetone drop method 
In this test, acetone drop applied to the plantar 
surface of the hind paw of diabetic rats resulted in 
cold allodynia, it was indicated by a decrease in 
reaction time as compared to normal rats. Animals 
treated with standard metformin (120 mg/kg) showed 
significant (P <0.05) decrease in reaction time at 3rd , 
4th and 5th of treatment schedule as compared to 
diabetic control rats. While animals treated with S. 
torvum methanolic extract (100 mg/kg) showed 
significant (P <0.05) decrease in reaction time at 3rd 
and 4th week of treatment schedule as compared to 
diabetic control rats (Fig. 7). 
 
Rota rod test 
Diabetic rats showed motor incoordination as 
indicated by significant (P <0.05) decrease in fall off 
time using rota rod apparatus. Diabetic rats treated 
with metformin (120 mg/kg) and S. torvum 
methanolic extract (30 and 100 mg/kg) showed 
significant (P <0.05) improvement in motor 
coordination as indicated by a decrease in fall off time 
as compared to diabetic control rats after 2nd week of 
treatment schedule as compared to diabetic control 
rats (Fig. 8). 
 
Hot plate method 
Heat hyperalgesia in diabetic rats was observed at 
the 3rd week of induction of diabetes. Heat 
hyperalgesia was indicated by a significant reduction 
in paw withdrawal latency as compared to normal 
rats. Diabetic rats treated with metformin (120 mg/kg) 
and S. torvum methanolic extract (100 mg/kg) showed 
significant (P <0.05) improvement in paw withdrawal 
latency at 3rd, 4th, and 5th week of treatment schedule 
as compared to diabetic control rats (Fig. 9). 
 
Blood glucose levels 
After treatment, blood glucose levels significantly 
(P <0.05) decrease in diabetic rats treated with 
metformin (120 mg/kg) and diabetic rats treated with 
S. torvum methanolic extract (100 mg/kg) as 
compared to diabetic control rats (Fig. 10). 
 
Relative organ weight 
There was significant (P <0.05) decrease in relative 
organ weight of pancreas of animals of diabetic 
control rats as compared with normal control rats, and 
significant (P <0.05) increase in relative organ weight 
of pancreas in diabetic rats treated with standard 
metformin (120 mg/kg) and in diabetic rats treated 
with S. torvum methanolic extract (30 and 100 mg/kg) 
as compared to diabetic control rats (Fig. 11). 
 
Fig. 5 — Effect of STME (30 and 100 mg/kg) and metformin
(120 mg/kg) on cold allodynia assessed by tail immersion in cold
water test in alloxan induced diabetic neuropathy in diabetic rats. 
N= 6, all data were subjected to ANOVA followed by Dunnett’s
test, the observations are mean±SEM. *P <0.05 as compare to 
normal control group and # P <0.05 as compared to diabetic 




Fig. 6 — Effect of STME (30 and 100 mg/kg) and metformin
(120 mg/kg) on heat hyperalgesia assessed by tail immersion in
hot water test in alloxan induced diabetic neuropathy in diabetic
rats. 
N= 6, all data were subjected to ANOVA followed by Dunnett’s
test, the observations are mean±SEM. *P <0.05 as compared to 
normal control group and # P <0.05 as compared to diabetic 




Fig. 7 — Effect of STME (30 and 100 mg/kg) and metformin
(120 mg/kg) on cold allodynia assessed by the acetone drop test in 
alloxan induced diabetic neuropathy in diabetic rats. 
N= 6, all data were subjected to ANOVA followed by Dunnett’s
test, the observations are mean±SEM. *P <0.05 as compared to 
normal control group and # P <0.05 as compared to diabetic 
control group; STME- Solanum torvum methanolic extract. 





In-vivo antioxidant studies like RGSH, TBARS 




RGSH is a primary antioxidant in the cell. 
significant (P <0.05) decrease in the amount of RGSH 
was observed in the diabetic control group compared 
with the normal control group, while in diabetic rats 
treated with metformin and S. torvum methanolic 
extract (30 and 100 mg/kg) showed a significant 
increase in RGSH levels as compared with the 
diabetic control group (Fig. 12). 
 
Thiobarbituric acid 
There was significant (P <0.05) increase in TBARS 
levels in the diabetic control rats as compared to normal 
rats, while diabetic rats treated with metformin, S. 
torvum methanolic extract (30 and 100 mg/kg ) showed 
significant (P <0.05) decrease in TBARS levels as 
compared with diabetic control rats (Fig. 13). 
 
Histopathological examination of the sciatic nerve 
The sciatic nerve of diabetic rats developed severe 
pathological changes as compared with the groups 
 
 
Fig. 8 — Effect of STME (30 and 100 mg/kg) and metformin
(120 mg/kg) on motor coordination assessed by the rota rod test in
alloxan induced diabetic neuropathy in diabetic rats. 
N= 6, all data were subjected to ANOVA followed by Dunnett’s
test, the observations are mean±SEM. *P <0.05 as compare to
normal control group and # P <0.05 as compared to diabetic
control group; STME- Solanum torvum methanolic extract. 
 
 
Fig. 9 — Effect of STME (30 and 100 mg/kg) and metformin
(120 mg/kg) on heat hyperalgesia assessed by hot plate method in
alloxan induced diabetic neuropathy in diabetic rats. 
N= 6, all data were subjected to ANOVA followed by Dunnett’s
test, the observations are mean±SEM. *P <0.05 as compared to
normal control group and # P <0.05 as compared to diabetic
control group; STME- Solanum torvum methanolic extract. 
 
 
Fig. 10 — Effect of STME (30 and 100 mg/kg) and metformin
(120 mg/kg) on blood glucose levels of alloxan induced diabetic
neuropathy in diabetic rats. 
N= 6, all data were subjected to ANOVA followed by Dunnett’s
test, the observations are mean±SEM. *P <0.05 as compared to
normal control group and # P <0.05 as compared to diabetic
control group; STME- Solanum torvum methanolic extract. 
 
Fig. 11 — Effect of STME (30 and 100 mg/kg) and metformin
(120 mg/kg)on relative organ weight of alloxan induced diabetic
neuropathy in diabetic rats. 
N= 6, all data were subjected to ANOVA followed by Dunnett’s 
test, the observations are mean±SEM. *P <0.05 as compared to 
normal control group and # P <0.05 as compared to diabetic 
control group; STME- Solanum torvum methanolic extract. 
 
 
Fig. 12 — Effect of STME (30 and 100 mg/kg) and metformin
(120 mg/kg) on reduced glutathione in blood serum of alloxan-
induced diabetic neuropathy in diabetic rats. 
N= 6, all data were subjected to ANOVA followed by Dunnett’s
test, the observations are mean±SEM. *P <0.05 as compared to 
the normal control group and # P <0.05 as compared to diabetic 
control group; STME- Solanum torvum methanolic extract. 
 
 
Fig. 13 — Effect of STME (30 and 100 mg/kg) and metformin
(120 mg/kg) on thiobarbituric acid levels in the pancreatic
homogenate of alloxan-induced diabetic neuropathy in diabetic 
rats. 
N= 6, all data were subjected to ANOVA followed by Dunnett’s
test, the observations are mean±SEM. *P <0.05 as compared to 
the normal control group and # P <0.05 as compared to diabetic 
control group; STME- Solanum torvum methanolic extract. 




treated with metformin and STME (30 and 100 mg/ 
kg). The sciatic nerve of normal control rat’s showing 
normal sciatic nerve fibres and normal outer 
membrane of blood vessel (Plate 1). The diabetic 
control group showed oedema round the epineurium 
and infiltration of neutrophils around the blood 
vessels and showed swelling of nerve fibres (Plate 2). 
Diabetic rats treated with metformin (120 mg/kg) 
showed swelling of nerve fibres and demylination of 
nerve fibres. (Plate 3). Macrophages and monocytes 
were observed around the Schwann cells of diabetic 
rats treated with STME (30 mg/kg), (Plate 4) while 
diabetic rats treated with STME (100 mg/ kg) showed 
mild oedema around the epineurium, few infiltrating 
neutrophils around the blood vessels and only minor 
swelling of nerve fibres (Plate 5). 
 
Discussion 
The present study shows the effect of S. torvum on 
diabetic neuropathy in alloxan-induced diabetic rats 
as assessed by its morphological, behavioural, 
biochemical and histopathological parameters. 
Reactive oxygen species (ROS) is a product of 
biochemical and physiological processes. 
Environmental stress increases the levels of free 
radical drastically, thereby disturbing the equilibrium 
between free radical production and the antioxidant 
levels resulting in oxidative stress because of excess 
ROS, antioxidant depletion, or both. With cellular 
production of ROS, damage to cellular 
macromolecules such as lipid, protein and DNA 
mutation in damaged target cells and tissue occurs 
resulting in cell death. This damage is associated with 
an increase in the risk of diseases such as diabetes and 
complications associated with diabetes, such as 
neuropathies, retinopathies, nephropathy etc1. A 
strong relationship exists between glycaemia and 
diabetic microvascular complications in both type I 
and type II diabetes. Generation of superoxide due to 
oxidative stress in diabetes may be responsible for 
vascular and neuronal complications of painful 
neuropathy. Early in the course of diabetes 
intracellular hyperglycemia causes the abnormality in 
blood flow with increased vascular permeability. 
Quantitative and qualitative abnormalities of extra 
vascular matrix contribute to an irreversible increase 
in vascular permeability. With time microvascular cell 
loss occurs resulting in programmed cell death. 
Hyperglycemia may also affect the production of 
factors for endothelial and neuronal cell death. 
 
 
Plate 1 — Section of H&E stained sciatic nerve of normal control
rat’s showing normal sciatic nerve fibres and normal outer 




Plate 2 — Section of H&E stained sciatic nerve of diabetic control
rats showed oedema around the epineurium and infiltration of





Plate 3 — Section of H&E stained sciatic nerve of diabetic rats
treated with metformin (120 mg/kg) showed swelling of nerve
fibres and demylination of nerve fibres (100X). 




Together these changes lead to oedema, ischemia, and 
hypoxia-induced neovascularization in the retina; 
proteinuria, mesangial matrix expansion, 
glomerulosclerosis in the kidney and multifocal axial 
degradation in peripheral nerves. Generation of super 
peroxide due to oxidative stress in diabetes may be 
responsible for vascular and neuronal complications 
of painful neuropathy. DN is a very common 
complication of diabetes. Peripheral nerve injury is 
associated with neuropathic pain and is characterized 
by sensory abnormalities such as unpleasant abnormal 
sensation, increased response to painful stimuli and 
pain in response to the stimulus that does not 
normally provoke pain and with motor incoordination. 
Alloxon and it’s reduction products dialuric acid, 
establish a redox cycle with the formation of super 
peroxide radical. These radicals undergo dismutation 
to hydrogen peroxide. The action of reactive oxygen 
species with a simultaneous massive increase in the 
cystolic calcium concentration causes rapid beta cell 
destruction29, hence, alloxan was selected in the 
present study. 
The present study indicated that methanolic extract 
of S. torvum seeds exhibited good antidiabetic and 
antioxidant activity when administered at the dose 100 
mg/kg orally. The high dose of STME (100 mg/kg), 
showed a similar effect as that of metformin (120 
mg/kg, oral hypoglycemic agent). The development of 
diabetes was observed after 72 hours of induction of 
diabetes by Alloxan monohydrate (150 mg/kg). The 
development of neuropathy was observed after 2nd 
week of induction of diabetes. In vitro assay of the 
present study indicates that percentage uptake of 
glucose by yeast cells was increased with increasing 
dose of STME at various concentration of glucose (5, 
10, and 25 mM). The STME at a higher concentration 
that is above 40 μL/mL exhibited glucose uptake 
activity comparable with standard metronidazole 
solution. The morphological study such as body weight 
and water intake was assessed once in a week. Diabetic 
rats showed significant decrease in body weight as 
compared to normal control rats. Diabetic rats treated 
with metformin (120 mg/kg) and STME (30 and  
100 mg/kg) showed significant improvement in body 
weight as compared to diabetic control rats in the 4th 
and 5th week of treatment schedule. Water intake was 
decreased in diabetic control rats as compared with 
normal control, metformin and STME treated  
diabetic rats. 
The behavioural parameters such as hyperalgesia, 
cold allodynia and motor coordination were assessed 
by using tail immersion test in hot and cold water, hot 
plate method, acetone drop test and rota rod test 
respectively. In behavioural tests, diabetic rats 
showed a significant reduction in tail and paw 
withdrawal latencies in tail immersion tests for hot 
and cold water and hot plate method respectively. A 
significant decrease in reaction time for acetone drop 
method and a significant decrease in fall off time for 
rota rod test was observed in diabetic rats as 
compared to normal control. 
In case of tail immersion test in cold and hot water, 
diabetic rats treated with metformin (120 mg/kg) and 
diabetic rats treated with STME (100 mg/kg) showed 
 
 
Plate 4 — Section of H&E stained sciatic nerve of diabetic rats
treated with STME (30 mg/kg) showed accumulation of




Plate 5 — Section of H&E stained sciatic nerve of diabetic rats
treated with STME (100 mg/kg) showed mild oedema around the
epineurium and few infiltrating neutrophils around blood vessels
and minor swelling of nerve fibres (100X). 




significant improvement in tail withdrawal latency in 
3rd, 4th and 5th week of treatment schedule as 
compared to diabetic control rats. In case of cold 
allodynia as assessed by acetone drop test, diabetic 
rats treated with metformin (120 mg/kg) showed a 
significant decrease in reaction time at 3rd, 4th, and 5th 
week of treatment schedule. Diabetic rats treated with 
STME (100 mg/kg) showed a significant decrease in 
reaction time at 3rd and 4th week of treatment 
schedule. As evident from the results of the present 
study, five-week treatment with STME (100 mg/kg) 
improved cold allodynia and thermal hyperalgesia in 
experimental animals. 
Motor incoordination was assessed by using rota rod 
test. Diabetic rats treated with metformin (120 mg/kg) 
and STME (30 and 100 mg/kg) showed significant 
improvement in motor coordination as indicated by a 
decrease in fall off time as compared to diabetic control 
rats after 2nd week of treatment schedule as compared to 
the diabetic control rats, thus treatment with STME, 
prevents motor incoordination in the diabetic rats. 
Heat hyperalgesia assessed by hot plate method, 
diabetic rats treated with metformin (120 mg/kg) and 
STME (100 mg/kg) showed significant improvement in 
paw withdrawal latency at 3rd, 4th, and 5th week of 
treatment schedule as compared to diabetic control rats. 
After treatment, blood glucose levels significantly 
decreased in diabetic rats treated with metformin (120 
mg/kg) and diabetic rats treated with STME (100 
mg/kg) as compared to diabetic control rats.  
There was a significant decrease in relative organ 
weight of pancreas of animals of diabetic control rats as 
compared with normal control rats, and a significant 
increase in relative organ weight of pancreas in diabetic 
rats treated with standard metformin (120 mg/kg) and in 
diabetic rats treated with STME (30 and 100 mg/kg) as 
compared to diabetic control rats. The purpose of 
relative organ weight analysis is to detect any direct 
treatment effect on the organ weights over and above 
any indirect effects caused by the effects of the treatment 
on body weight. 
Thiobarbituric acid reactive substances are formed 
as a byproduct of lipid peroxidation (degradation 
products of fats) which can be detected by TBARS 
assay using Thiobarbituric acid as a reagent. Since 
reactive oxygen species have short half-lives they are 
difficult to measure directly, so that it can be 
measured by several products of damage produced by 
oxidative stress, such as TBARS. Assay measures 
malonaldehyde present in the sample, as well as 
malonaldehyde generated from lipid hydro peroxidase 
by the hydrolytic conditions of the reaction5,30. 
Glutathione (GSH) is highly abundant in all cell 
compartments and is the major soluble antioxidant. 
Reduced GSH/Oxidized GSH ratio is a major 
determinant of oxidative stress. GSH shows its 
antioxidant effects in several ways. It detoxifies 
hydrogen peroxide and lipid peroxides via the action of 
GSH-Peroxidase30. 
RGSH is a primary antioxidant in the cell. Significant 
decrease in the amount of RGSH was observed in the 
diabetic control group compared with a normal control 
group, while in diabetic rat treated with metformin and 
STME (30 and 100 mg/kg) showed a significant 
increase in RGSH levels as compared with the diabetic 
control group. In case of TBARS, there was a significant 
increase in TBARS levels in the diabetic control rats as 
compared to normal rats, while diabetic rats treated with 
STME (30 and 100 mg/kg ) showed a significant 
decrease in TBARS levels as compared with diabetic 
control rats, indicating the antioxidant activity of STME. 
We observed that the sciatic nerve of diabetic rats 
produced severe pathological changes as compared with 
groups treated with metformin and STME (30 and 100 
mg/ kg). The diabetic control group showed oedema 
round the epineurium and infiltration of neutrophils 
around the blood vessels and showed swelling of the 
nerve. Diabetic rats treated with metformin (120 mg/kg) 
showed swelling of nerve fibres and demylination of 
nerve fibres, while diabetic rats treated with STME (100 
mg/ kg) showed mild oedema around the epineurium 
with few infiltrating neutrophils around the blood 
vessels and only minor swelling of nerve fibres, thus 
STME treated animals showed sciatic nerve stability 
than diabetic control animals.  
The present study has shown the effect of S. torvum 
on alloxan-induced diabetic neuropathy in diabetic rats 
by assessing its morphological, behaviour, antioxidant 
and histopathological studies. Treatment with  
S. torvum (100 mg/kg) in diabetic rats showed 
significant improvement in tail withdrawal latency in 
case of a hot plate, tail immersion in hot and cold water, 
and increase in reaction time for acetone drop test and 
improvement in motor coordination assessed by rota rod 
test. Significant increase in relative organ weight was 
observed in STME (100 mg/kg) treated group. Increase 
in RGSH and decrease in TBARS levels were observed 
in STME (100 mg/kg) treated groups. STME  
(100 mg/kg) has also reversed histopathological changes 
as seen in diabetic control animals. 





Thus it can be concluded that the methanolic 
extract of S. torvum (100 mg/kg) has a 
neuroprotective, antioxidant, and antidiabetic effect 
against alloxan-induced diabetic rats.  
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